NCT00303576View on ClinicalTrials.gov

A Safety and Tolerability Study of Dapivirine (TMC120) Vaginal Microbicide Gel

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

July 31, 2006

Conditions
HIV Infections
Interventions
DRUG

dapivirine (TMC120) vaginal gel

Trial Locations (4)

Unknown

Projet Ubuzima, Kigali

Reproductive Health Research Unit - Sheshisani IPM Clinic, Yeoville

Farmovs-Parexel, Bloemfontein

Kilimanjaro Reproductive Health Program, Moshi

All Listed Sponsors
lead

International Partnership for Microbicides, Inc.

INDUSTRY

NCT00303576 - A Safety and Tolerability Study of Dapivirine (TMC120) Vaginal Microbicide Gel | Biotech Hunter | Biotech Hunter